Metastatic Adenocarcinomas of the Gastroesophageal Junction
Also known as: Metastatic Adenocarcinoma of the Gastro-Esophageal Junction / Metastatic Adenocarcinoma of the Gastroesophageal Junction
Drug | Drug Name | Drug Description |
---|---|---|
DB09037 | Pembrolizumab | A PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma. |
DB00072 | Trastuzumab | A monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB09037 | Pembrolizumab | Programmed cell death protein 1 | target |
DB09037 | Pembrolizumab | Programmed cell death 1 ligand 1 | target |
DB00072 | Trastuzumab | Receptor tyrosine-protein kinase erbB-2 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB05578 | Ramucirumab | Not Available | Completed | 1 |
DB05578 | Ramucirumab | Not Available | No Longer Available | 1 |
DB09343 | Tipiracil | Not Available | Completed | 1 |
DB00432 | Trifluridine | Not Available | Completed | 1 |